{"transactions":[{"id":1034167,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75053,"kind":"person","name":"Chaturvedi Vipin","position":1,"cik":"0001971423","reported_name":"Chaturvedi Vipin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-22T20:05:47.000Z","date":"2025-09-18","kind":"grant","planned":false,"acquired":true,"shares":43222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 29,923 shares vested in full upon the date of grant and options to purchase 13,299 shares will vest in 12 substantially equal quarterly installments such that the stock option is fully vested on the third anniversary of the date of grant."}],"balance_after":43222,"derivative":{"exercise_price":1.93,"expiration_date":"2035-09-18","underlying":"Common Stock","underlying_shares":43222},"source":{"system":"sec-edgar","filing":"0001971423-25-000003","document":"wk-form4_1758571544.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000197142325000003/wk-form4_1758571544.xml","form_type":"4"}},{"id":1054265,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75053,"kind":"person","name":"Chaturvedi Vipin","position":1,"cik":"0001971423","reported_name":"Chaturvedi Vipin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-27T12:24:57.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":11854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 7,424 shares vested in full upon the date of grant and options to purchase 4,430 shares will vest in 12 substantially equal quarterly installments such that the stock option is fully vested on the third anniversary of the date of grant."}],"balance_after":11854,"derivative":{"exercise_price":1.41,"expiration_date":"2035-08-26","underlying":"Common Stock","underlying_shares":11854},"source":{"system":"sec-edgar","filing":"0001824293-25-000140","document":"wk-form4_1756297493.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429325000140/wk-form4_1756297493.xml","form_type":"4"}},{"id":1295287,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75053,"kind":"person","name":"Chaturvedi Vipin","position":1,"cik":"0001971423","reported_name":"Chaturvedi Vipin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-24T22:58:17.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":43319,"price":0.6857,"value":29703.8383,"ownership":{"direct":true},"balance_after":43319,"derivative":{"exercise_price":0.6857,"exercise_date":"2025-01-23","expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":43319},"source":{"system":"sec-edgar","filing":"0001824293-25-000034","document":"wk-form4_1737759490.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429325000034/wk-form4_1737759490.xml","form_type":"4"}},{"id":1914702,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":75053,"kind":"person","name":"Chaturvedi Vipin","position":1,"cik":"0001971423","reported_name":"Chaturvedi Vipin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-04-24T22:29:39.000Z","date":"2023-04-21","kind":"grant","planned":false,"acquired":true,"shares":172189,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Received in exchange for 4,600,000 shares of common stock of GRI Bio, Inc. (\"GRI\"), pursuant to the Agreement and Plan of Merger, dated December 13, 2022, by and among Vallon Pharmaceuticals, Inc. (the \"Company\"), Vallon Merger Sub, Inc. and GRI Bio, Inc. (the \"Merger\"). Per the terms of the Merger, each share of GRI common stock was converted into the right to receive 0.0374 shares of the Company's common stock. In connection with the Merger, the Company effected a reverse stock split of the Company's common stock at a ratio of 1-for-30 (the \"Reverse Split\"). Unless noted otherwise, all references to share amounts in this Form 4 reflect the Reverse Split."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 4,600,000 shares of common stock of GRI Bio, Inc. (\"GRI\"), pursuant to the Agreement and Plan of Merger, dated December 13, 2022, by and among Vallon Pharmaceuticals, Inc. (the \"Company\"), Vallon Merger Sub, Inc. and GRI Bio, Inc. (the \"Merger\"). Per the terms of the Merger, each share of GRI common stock was converted into the right to receive 0.0374 shares of the Company's common stock. In connection with the Merger, the Company effected a reverse stock split of the Company's common stock at a ratio of 1-for-30 (the \"Reverse Split\"). Unless noted otherwise, all references to share amounts in this Form 4 reflect the Reverse Split."}],"balance_after":172189,"source":{"system":"sec-edgar","filing":"0001824293-23-000102","document":"wf-form4_168237536636728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429323000102/wf-form4_168237536636728.xml","form_type":"4"}}]}